In a filing, Harmony Biosciences Holdings Inc revealed its CHIEF FINANCIAL OFFICER Kapadia Sandip unloaded Company’s shares for reported $0.23 million on Apr 01 ’25. In the deal valued at $32.54 per share,6,987 shares were sold. As a result of this transaction, Kapadia Sandip now holds 0 shares worth roughly $0.0.
Then, SANDIP KAPADIA bought 6,986 shares, generating $231,865 in total proceeds.
Before that, Dierks Jeffrey sold 4,869 shares. Harmony Biosciences Holdings Inc shares valued at $159,090 were divested by the CHIEF COMMERCIAL OFFICER at a price of $32.67 per share. As a result of the transaction, Dierks Jeffrey now holds 0 shares, worth roughly $0.0.
Deutsche Bank initiated its Harmony Biosciences Holdings Inc [HRMY] rating to a Buy in a research note published on February 11, 2025; the price target was $55. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who began to cover the stock in mid December with a ‘”a Buy”‘ rating. UBS started covering the stock on September 10, 2024. It rated HRMY as “a Buy”.
Price Performance Review of HRMY
On Friday, Harmony Biosciences Holdings Inc [NASDAQ:HRMY] saw its stock jump 0.62% to $29.17. Over the last five days, the stock has lost -0.31%. Harmony Biosciences Holdings Inc shares have fallen nearly -15.23% since the year began. Nevertheless, the stocks have fallen -0.68% over the past one year. While a 52-week high of $41.61 was reached on 01/21/25, a 52-week low of $26.47 was recorded on 04/09/25. SMA at 50 days reached $34.29, while 200 days put it at $34.80.
Levels Of Support And Resistance For HRMY Stock
The 24-hour chart illustrates a support level at 28.07, which if violated will result in even more drops to 26.98. On the upside, there is a resistance level at 29.82. A further resistance level may holdings at 30.48. The Relative Strength Index (RSI) on the 14-day chart is 32.97, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.99, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 66.73%. Stochastics %K at 29.02% indicates the stock is a holding.
How much short interest is there in Harmony Biosciences Holdings Inc?
A steep rise in short interest was recorded in Harmony Biosciences Holdings Inc stocks on 2025-03-31, dropping by -0.4 million shares to a total of 3.49 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-28 was 3.9 million shares. There was a decline of -11.55%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on June 21, 2024 when Citigroup began covering the stock and recommended ‘”a Buy”‘ rating along with a $48 price target.
